unsym-fac-(exo-OH)-[Co(dien)(dapo)(N3)][ZnCl4]

Rebecca J. Browne, David A. Buckingham, Allan G. Blackman, Charles R. Clark

Acta Crystallographica Section E Structure Reports Online, 2002

Abstract

Structural analysis of the title compound, [N-(2-amino­ethyl)-1,2-ethanedi­amine]­azido(2-hydroxy-1,3-propane­di­amine)­cobalt(III) tetra­chloro­zincate(II), unsym-fac-(exo-OH)-[Co(dien)(dapo)N3]ZnCl4 or [Co(N3)(C4H13N3)(C3H10N2O)][ZnCl4], confirms both the facial configuration of the N-(2-amino­ethyl)-1,2-ethanedi­amine (dien) ligand and the exo stereochemistry of the OH substituent of the 2-hydroxy-1,3-propane­di­amine (dapo) ligand relative to the azide ligand.

Read the paper

• DOI
• Publisher page

Related studies

• Meta-analysis and the science of research synthesis Nature, 2018
• Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology, 2016
• Cluster Randomized Controlled Trial Stroke, 2015
• Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Lancet (London, England), 2021
• Disease Free Survival and Local Recurrence for Laparoscopic Resection Compared to Open Resection of Stage II-III Rectal Cancer: Follow up Results of the ACOSOG Z6051 Randomized Controlled Trial Annals of Surgery, 2019
• The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial Journal of Child Psychology and Psychiatry and Allied Disciplines, 2015

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free